|
|
 |
Would you like to leave a message? alfresco log in vgr New U.S. legislation requires the agency to inspect global plants on the same schedule as domestic facilities, and to clear its backlog of drug applications within five years. Indian firms account for more than one-third of U.S. drug approval filings.
2021-8-5 21:57:57 |
|
|
|
